Table 4 Overall and sex-stratified analysis of rs4293393 association with TUG, frailty and morbidity index outcomes at follow-up (cross-sectional analysis).
Phenotype | UMOD rs4293393 | |
---|---|---|
AG | GG | |
TUG ≥ 10 s | OR [95% CI], P | |
Overall | 1.32 [0.93–1.89], P = 0.102 | 1.00[0.46–2.20], P = 0.988 |
Women | 1.10 [0.68–1.77], P = 0.708 | 1.40 [0.47–4.11], P = 0.544 |
Men | 0.50 [0.29–0.85], P = 0.011 | 0.70 [0.22–2.23]; P = 0.545 |
Prefrail/frail | OR [95% CI], P | |
Overall | 1.20 [0.91–1.59], P = 0.174 | 1.18 [0.61–2.27], P = 0.620 |
Women | 0.85 [0.58–1.24], P = 0.386 | 1.84 [0.69–4.93], P = 0.222 |
Men | 0.81[0.55–1.21, P = 0.299 | 0.77 [0.30–1.95], P = 0.580 |
Morbidity index ≥ 1 | OR [95% CI], P | |
Overall | 1.01 [0.75–1.37], P = 0.940 | 0.96 [0.47–1.96], P = 0.919 |
Women | 1.24 [0.81–1.89], P = 0.325 | 0.82 [0.31–2.16], P = 0.692 |
Men | 0.78 [0.51–1.21], P = 0.271 | 1.16 [0.39–3.46], P = 0.786 |